Wednesday, 12 April 2023

SII to restart vaccine production amid surge in Covid cases

Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus infections in India.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/VuzwUDa
via ATC

ATC ALL TIPS N CLIPS

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

0 comments:

Post a Comment

 

Copyright @ 2013 ATC __News.